Paper6985698
Cancer of the breast: the past decade (first of two parts).
Henderson IC and 1 other. N Engl J Med, 1980. Cited by 448 papers, by iCite.
Cite this record
ConductScience Library. Cancer of the breast: the past decade (first of two parts). Papers, record 6985698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6985698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Adrenalectomy | |
| Castration | |
| Female | |
| Follow-Up Studies | |
| Hormones | |
| Humans | |
| Hypophysectomy | |
| Mammography | |
| Mastectomy | |
| Neoplasm Metastasis | |
| Neoplasm Staging | |
| Prognosis | |
| Random Allocation | |
| Time Factors |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 448 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36795198 | Nanomedicine in therapeutic warfront against estrogen receptor-positive breast cancer. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/36795198 | PubMed |
| 34524841 | NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers. | Sci Adv | 2021 | https://conductscience.org/library/papers/34524841 | PubMed |
| 34124226 | A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies. | Front Vet Sci | 2021 | https://conductscience.org/library/papers/34124226 | PubMed |
| 32707666 | Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32707666 | PubMed |
| 32485679 | 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future. | J Mol Endocrinol | 2020 | https://conductscience.org/library/papers/32485679 | PubMed |
| 27801993 | Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer. | Cancer Sci | 2017 | https://conductscience.org/library/papers/27801993 | PubMed |
| 26069501 | Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics. | Cancer Nanotechnol | 2013 | https://conductscience.org/library/papers/26069501 | PubMed |
| 22866165 | Effect of tumour necrosis factor-alpha on estrogen metabolic pathways in breast cancer cells. | J Cancer | 2012 | https://conductscience.org/library/papers/22866165 | PubMed |
| 22675673 | Radiation, inflammation, and immune responses in cancer. | Front Oncol | 2012 | https://conductscience.org/library/papers/22675673 | PubMed |
| 21290426 | In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs. | Arch Pharm (Weinheim) | 2011 | https://conductscience.org/library/papers/21290426 | PubMed |
| 20556210 | Synthesis and antiproliferative activity of coumarin-estrogen conjugates against breast cancer cell lines. | Lett Drug Des Discov | 2009 | https://conductscience.org/library/papers/20556210 | PubMed |
| 18991629 | A review of coumarin derivatives in pharmacotherapy of breast cancer. | Curr Med Chem | 2008 | https://conductscience.org/library/papers/18991629 | PubMed |
| 18748967 | The halsted mastectomy. | West J Med | 1981 | https://conductscience.org/library/papers/18748967 | PubMed |
| 17429562 | A new hormonal therapy for estrogen receptor-negative breast cancer. | World J Surg | 2007 | https://conductscience.org/library/papers/17429562 | PubMed |
| 12114657 | From Endocrinology to Intracrinology. | Endocr Pathol | 1998 | https://conductscience.org/library/papers/12114657 | PubMed |
| 11091546 | Growth of Breast Cancer and Limited Surgery. | Breast Cancer | 1996 | https://conductscience.org/library/papers/11091546 | PubMed |
| 10947336 | New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits. | Pharmacoeconomics | 2000 | https://conductscience.org/library/papers/10947336 | PubMed |
| 9712568 | Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. | Ann Surg | 1998 | https://conductscience.org/library/papers/9712568 | PubMed |
| 8174206 | Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8174206 | PubMed |
| 8123487 | Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8123487 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6985698
GET https://conductscience.org/api/papers/v1/6985698/cited_by?page=2